Schirmer et al. reported that ivabradine modulated inflammatory cytokine gene expression and increased endothelial nitricoxide synthase (eNOS) activity in a murine model of hypercholesterolemic atherosclerosis [21]. The gene discussed is NOS3; the disease is atherosclerosis.